DOCE Research Christiane Hampe, PhD, Receives NIH R01

Dr. Christiane Hampe, PhD, has been awarded an NIH R01 for her project entitled “Islet Cell Membrane Antibodies in Diabetes”. The goals of this research are a) to investigate anti-idiotypic antibodies (anti-Id) directed against autoantibodies to glutamate decarboxylase (GAD65Ab) in human Type 1 Diabetes (T1D), and b) to develop anti-Id as a therapeutic tool for the elimination of GAD65-specific B lymphocytes. The results from this project will be crucial for the further development of a novel preventative therapy. Dr. Hampe is Associate Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.